mesothelioma

Ultimovacs’ cancer vaccine shows survival benefit in BMS combo trial despite missing primary endpoint

Ultimovacs, the Norwegian biotech company, has staged a remarkable comeback for its cancer vaccine candidate. Despite encountering a setback earlier ...